Delivery Order SPE2DB20D2104-SPE2DB25F1402
Award Date
10/30/24
Potential Completion Date
10/31/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,061.86 firm fixed-price delivery order contract is for the provision of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S medication. The contract has an ultimate completion date of August 7, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) awarded a $3,217.50 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S medication. The contract has an ultimate completion date of May 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,400.84, is for the delivery of pharmaceutical products including the drug MYFEMBREE. The contract is a Firm Fixed Price Delivery Order with a completion date of November 8, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of the pharmaceutical product MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S. The contract is a Delivery Order with a Firm Fixed Price of $2,190.63, and has an Ultimate Completion Date of June 9, 2025. The award was made by the Defense Logistics Agency, a Defense agency, on June 6, 2025. This contract is not set-aside and is open to full and open...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,150.67 firm fixed-price delivery order contract, awarded on October 31, 2024, is for "PHARMACEUTICAL PV DIV - FSB" and has an ultimate completion date of October 31, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a $13,100.16 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on July 1, 2025. The contract provides for the delivery of the pharmaceutical product MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S by July 2, 2025. This contract is not set aside for any particular business category. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM) and...
This federal contract award (SPE2DB20D1100|SPE2DB24FB1R6) was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $14,726.53 fixed-price delivery order is for the pharmaceutical product MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S. This contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by...
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FG1TH, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,547.13 delivery order contract is for the supply of the medication MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 5, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The current Delivery Order, valued at $4,402.80, is for the supply of 4559592833 - Junel FE 1.5 mg-30 mcg tablets, with a completion date of January 13, 2023. This IDC serves as a primary vehicle for Amerisourcebergen to provide a...
The federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,989.68 firm fixed-price delivery order, awarded on February 15, 2024, supports the supply of a wide range of pharmaceutical products and medical supplies to federal healthcare programs. The contract has an ultimate completion date of February 16, 2024 and is not designated with a set-aside...